Hasil Pencarian - Andrew Hendifar
Anda harus masuk terlebih dahulu
- Menampilkan 1 - 14 hasil dari 14
-
1
Molecular Targets, Pathways, and Therapeutic Implications for Hepatocellular Carcinoma oleh Jun Gong, Jeremy Chuang, May Cho, Kyra Toomey, Andrew Hendifar, Daneng Li
Diterbitkan 2020-07-01Dapatkan teks lengkap
Artikel -
2
-
3
Fecal elastase, an assay for exocrine pancreatic insufficiency, has clinical utility in patients with pancreatic ductal adenocarcinoma oleh Jun Gong, Michelle Guan, Christopher E. Forsmark, Maria Q. Petzel, Veronica Placencio-Hickok, Andrew Hendifar
Diterbitkan 2020-12-01Dapatkan teks lengkap
Artikel -
4
Influence of Body Mass Index and Albumin on Perioperative Morbidity and Clinical Outcomes in Resected Pancreatic Adenocarcinoma. oleh Andrew Hendifar, Arsen Osipov, Jasleen Khanuja, Nicholas Nissen, Jason Naziri, Wensha Yang, Quanlin Li, Richard Tuli
Diterbitkan 2016-01-01Dapatkan teks lengkap
Artikel -
5
Combination systemic therapies with immune checkpoint inhibitors in pancreatic cancer: overcoming resistance to single-agent checkpoint blockade oleh Jun Gong, Andrew Hendifar, Richard Tuli, Jeremy Chuang, May Cho, Vincent Chung, Daneng Li, Ravi Salgia
Diterbitkan 2018-10-01Dapatkan teks lengkap
Artikel -
6
Combined morphologic and metabolic pipeline for Positron emission tomography/computed tomography based radiotherapy response evaluation in locally advanced pancreatic adenocarcinom... oleh Yi Lao, John David, Arman Torosian, Veronica Placencio, Yalin Wang, Andrew Hendifar, Wensha Yang, Richard Tuli
Diterbitkan 2019-01-01Dapatkan teks lengkap
Artikel -
7
-
8
Therapeutic Advances and Challenges in the Management of HER2-Positive Gastroesophageal Cancers oleh Jeremy Chuang, Samuel Klempner, Kevin Waters, Katelyn Atkins, Joseph Chao, May Cho, Andrew Hendifar, Alexandra Gangi, Miguel Burch, Pareen Mehta, Jun Gong
Diterbitkan 2022-04-01Dapatkan teks lengkap
Artikel -
9
-
10
Treatment strategies and clinical outcomes of locally advanced pancreatic cancer patients treated at high-volume facilities and academic centers oleh John M. David, MD, Sungjin Kim, MS, Veronica R. Placencio-Hickok, PhD, Arman Torosian, BS, Andrew Hendifar, MD, Richard Tuli, MD, PhD
Diterbitkan 2019-04-01Dapatkan teks lengkap
Artikel -
11
Author Correction: Phase I trial of Bermekimab with nanoliposomal irinotecan and 5‑fuorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma oleh Jun Gong, Shant Thomassian, Sungjin Kim, Gillian Gresham, Natalie Moshayedi, Jason Y. Ye, Julianne C. Yang, Jonathan P. Jacobs, Simon Lo, Nick Nissen, Srinivas Gaddam, Mourad Tighiouart, Arsen Osipov, Andrew Hendifar
Diterbitkan 2022-11-01Dapatkan teks lengkap
Artikel -
12
Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma oleh Jun Gong, Shant Thomassian, Sungjin Kim, Gillian Gresham, Natalie Moshayedi, Jason Y. Ye, Julianne C. Yang, Jonathan P. Jacobs, Simon Lo, Nick Nissen, Srinivas Gaddam, Mourad Tighiouart, Arsen Osipov, Andrew Hendifar
Diterbitkan 2022-09-01Dapatkan teks lengkap
Artikel -
13
COVID-19 Pandemic Impact on Diagnosis, Stage, and Treatment of Hepatocellular Carcinoma in the United States oleh Bhupinder Kaur, Yee Hui Yeo, Jeff Liang, Michael Luu, Walid Ayoub, Alexander Kuo, Hirsh Trivedi, Kamya Sankar, Jun Gong, Andrew Hendifar, Arsen Osipov, Kambiz Kosari, Nicholas Nissen, Mazen Noureddin, Amit G. Singal, Ju Dong Yang
Diterbitkan 2024-01-01Dapatkan teks lengkap
Artikel -
14
Keratin 17 modulates the immune topography of pancreatic cancer oleh Lyanne Delgado-Coka, Michael Horowitz, Mariana Torrente-Goncalves, Lucia Roa-Peña, Cindy V. Leiton, Mahmudul Hasan, Sruthi Babu, Danielle Fassler, Jaymie Oentoro, Ji-Dong K Bai, Emanuel F. Petricoin, Lynn M. Matrisian, Edik Matthew Blais, Natalia Marchenko, Felicia D. Allard, Wei Jiang, Brent Larson, Andrew Hendifar, Chao Chen, Shahira Abousamra, Dimitris Samaras, Tahsin Kurc, Joel Saltz, Luisa F. Escobar-Hoyos, Kenneth R. Shroyer
Diterbitkan 2024-05-01Dapatkan teks lengkap
Artikel